Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND Salmonella enterica is a major global food-borne pathogen, causing life-threatening infections. Ciprofloxacin and extended-spectrum cephalosporins (ESCs) are the drugs of choice for severe infections. We previously reported a ciprofloxacin-resistant S. enterica serotype Kentucky (S Kentucky) ST198-X1 strain that emerged in Egypt and spread throughout Africa and the Middle East from 2002 to 2008. We aimed to monitor recent trends in the location of transmission and antimicrobial resistance of this strain. METHODS We analysed isolates of S Kentucky collected by the French national surveillance system for salmonellosis in France from Jan 1, 2000, to Dec 31, 2011, and at two sites in Casablanca, Morocco, between Jan 1, 2003, and Dec 31, 2011. We analysed patterns of travel of patients infected with a ciprofloxacin-resistant strain of S Kentucky. We identified isolates showing resistance to ESCs or decreased susceptibility to carbapenems, characterised isolates by XbaI-pulsed field gel electrophoresis and multilocus sequence typing, and assessed mechanisms of bacterial resistance to antimicrobial drugs. FINDINGS 954 (1%) of 128,836 serotyped Salmonella spp isolates in France were identified as S Kentucky, as were 30 (13%) of 226 Salmonella spp isolates from Morocco. During 2000-08, 200 (40%) of 497 subculturable isolates of S Kentucky obtained in France were resistant to ciprofloxacin, compared with 376 (83%) of 455 isolates in 2009-11, suggesting a recent increase in ciprofloxacin resistance in France. Travel histories suggested S Kentucky infections originated predominantly in east Africa, north Africa, west Africa, and the Middle East, but also arose in India. We report several occurrences of acquisition of extended-spectrum β-lactamase (CTX-M-1, CTX-M-15), plasmid-encoded cephalosporinase (CMY-2), or carbapenemase (OXA-48, VIM-2) genes by ciprofloxacin-resistant isolates of S Kentucky ST198-X1 from the Mediterranean area since 2009. Many of these highly drug-resistant isolates were also resistant to most aminoglycosides, to co-trimoxazole (trimethoprim-sulfamethoxazole), and to azithromycin. INTERPRETATION The potential risk to public health posed by ciprofloxacin-resistant S Kentucky ST198-X1 warrants its inclusion in national programmes for the control of S. enterica in food-producing animals, in particular in poultry. FUNDING Institut Pasteur, Institut de Veille Sanitaire, Fondation pour la Recherche Médicale, French Government Investissement d'Avenir programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three MDR serotype Kentucky isolates (see below) were ST198, clustered into the HC2000_528 superlineage”
From Contamination of street food with multidrug-resistant Salmonella, in Ouagadougou, Burkina Faso (2021) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Global Burden of Nontyphoidal Salmonella Gastroenteritis
Majowicz, S. E., Musto, J., Scallan, E., Angulo, F. J., Kirk, M., O’Brien, S. J., Jones, T. F., Fazil, A., & Hoekstra, R. M. (2010) · Clinical Infectious Diseases · doi:10.1086/650733 · Cited by 2,442
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,027
Detection of erythromycin-resistant determinants by PCR
Sutcliffe, J., Grebe, T., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2562 · Cited by 989
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Rapid Detection of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Poirel, L., & Dortet, L. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1809.120355 · Cited by 761
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
A National Outbreak of Salmonella enteritidis Infections from Ice Cream
Hennessy, T. W., Hedberg, C. W., Slutsker, L., White, K. E., Besser-Wiek, J. M., Moen, M. E., Feldman, J., Coleman, W. W., Edmonson, L. M., MacDonald, K. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605163342001 · Cited by 389
Le Hello, S., Hendriksen, R. S., Doublet, B., Fisher, I., Nielsen, E. M., Whichard, J. M., Bouchrif, B., Fashae, K., Granier, S. A., Jourdan-Da Silva, N., et al. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jir409 · Cited by 277
Self-citationThe Emergence in Taiwan of Fluoroquinolone Resistance in Salmonella enterica Serotype Choleraesuis
Chiu, C.-H., Wu, T.-L., Su, L.-H., Chu, C., Chia, J.-H., Kuo, A.-J., Chien, M.-S., & Lin, T.-Y. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012261 · Cited by 272
Cited by
Crump, J. A., Sjölund-Karlsson, M., Gordon, M. A., & Parry, C. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-15 · Cited by 1,156
Genomic insights into the emergence and spread of antimicrobial-resistant bacterial pathogens
Baker, S., Thomson, N., Weill, F.-X., & Holt, K. E. (2018) · Science · doi:10.1126/science.aar3777 · Cited by 401
Self-citationMadec, J.-Y., Haenni, M., Nordmann, P., & Poirel, L. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.013 · Cited by 250
Woodford, N., Wareham, D. W., Guerra, B., & Teale, C. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt392 · Cited by 250
Guerra, B., Fischer, J., & Helmuth, R. (2014) · Veterinary Microbiology · doi:10.1016/j.vetmic.2014.02.001 · Cited by 178
Metadata
- Authors
- Le Hello, S., Harrois, D., Bouchrif, B., Sontag, L., Elhani, D., Guibert, V., Zerouali, K., & Weill, F.-X.
- Affiliations
- Institut Pasteur (FR)
- Institut Pasteur du Maroc (MA)
- Centre Hospitalier Universitaire Ibn Rochd (MA)
- Corresponding author
- Weill, François-Xavier
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 13
- Issue
- 8
- Pages
- 672-679
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2074192765
- Semantic Scholar
- 35623680c1b3a906362e60677dfb4c5e00034582
- Cited by
- 186
- References
- 31
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 11 · 2023: 12 · 2022: 16 · 2021: 16 · 2020: 15 · 2019: 14 · 2018: 11 · 2017: 13 · 2016: 17 · 2015: 14 · 2014: 23 · 2013: 9
- FWCI
- 31.32
- Type
- journal article
- Language
- en
- Open access
- green
- pasteur.hal.science
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- Greater South Information System
- Funders
- French Government “Investissement d'Avenir” programme (ANR-10-LABX-62-IBEID)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- ciprofloxacin resistance, extended-spectrum cephalosporins, carbapenem resistance, antimicrobial resistance, extended-spectrum beta-lactamase, CTX-M-15, CMY-2, OXA-48, VIM-2, plasmid-mediated resistance genes, travel-associated transmission, molecular epidemiology, multilocus sequence typing
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aminoglycosides, Anti-Bacterial Agents, Bacterial Proteins, beta-Lactamases, Child, Ciprofloxacin, Female, France, Humans, Male, Microbial Sensitivity Tests, Morocco, Salmonella Infections, Travel, Trimethoprim, Sulfamethoxazole Drug Combination, Azithromycin, Salmonella enterica, Drug Resistance, Multiple, Bacterial, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. https://app.cochat.ai/papers/10.1016/s1473-3099(13)70124-5
- The paper
- Le Hello, S., Harrois, D., Bouchrif, B., Sontag, L., Elhani, D., Guibert, V., Zerouali, K., & Weill, F.-X. (2013). Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(13)70124-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
